Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions

E-ISSN： 1873-4286|18|12|1609-1619

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.12, 2012-04, pp. : 1609-1619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival

Current Drug Targets, Vol. 12, Iss. 4, 2011-04 ,pp. : 556-562

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease

Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. : 937-943

Bentham Science Publishers

Access to resources Recommend Favorite

Neutrophil-mediated Platelet Activation: A Key Role for Serine Proteinases

By Renesto P. Chignard M.

General Pharmacology, Vol. 26, Iss. 5, 1995-09 ,pp. : 905-910

Elsevier

Access to resources Recommend Favorite

A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

By Nakamura M. Zhao Z.-Q. Clark K.L. Velez D.V. Guyton R.A. Vinten-Johansen J.

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1

Current Drug Metabolism, Vol. 16, Iss. 6, 2015-07 ,pp. : 486-503

Bentham Science Publishers

Access to resources Recommend Favorite